1Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, ...

1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, ...

Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex Open Access Linjie Yuan; Wenzhi Ji; Brendan G. Dwyer; Joey Lu; Jing Bian; ...

CCR7 overexpression enhances CAR-T–cell anti-lymphoma activity by directing therapeutic cells to lymph nodes and intrinsically strengthening their cytotoxic function, suggesting that accounting for ...

, South Australian immunoGENomics Cancer Institute, Adelaide, Australia. 2Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia. Search for other ...

An artificial intelligence model called Clairity Breast, which uses mammogram images to predict the 5-year likelihood of breast cancer, was recently launched in Massachusetts. The first to receive FDA ...

Department of Bio-therapeutic, The First Medical Center, Chinese PLA General Hospital (Medical School of Chinese PLA), Beijing, China.

Researchers focused on current or future research projects may desire assistance in the preparation of manuscripts reporting completed research. Many companies now fill this demand by offering ...

Abstract. Antibody-drug conjugates (ADCs) enable the specific targeting of a potent cytotoxic drug to cancer cells expressing a select antigen via the release of the cytotoxin covalently linked to a ...

School of Pharmaceutical Sciences - USM, Penang, Malaysia.

Search for other works by this author on: ...

Abstract. Breast cancers with high expression of estrogen receptor (ER), progesterone receptor (PR), or Human Epidermal Growth Factor Receptor 2 (HER2) have benefited dramatically from ...